These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 9770244)

  • 1. Oxidative damage in the central nervous system: protection by melatonin.
    Reiter RJ
    Prog Neurobiol; 1998 Oct; 56(3):359-84. PubMed ID: 9770244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin oxidative stress and neurodegenerative diseases.
    Srinivasan V
    Indian J Exp Biol; 2002 Jun; 40(6):668-79. PubMed ID: 12587715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative toxicity in models of neurodegeneration: responses to melatonin.
    Reiter RJ; Garcia JJ; Pie J
    Restor Neurol Neurosci; 1998 Jun; 12(2-3):135-42. PubMed ID: 12671308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of oxygen toxicity by melatonin.
    Reiter RJ; Tan DX; Qi WB
    Zhongguo Yao Li Xue Bao; 1998 Nov; 19(6):575-81. PubMed ID: 10437151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin as a pharmacological agent against neuronal loss in experimental models of Huntington's disease, Alzheimer's disease and parkinsonism.
    Reiter RJ; Cabrera J; Sainz RM; Mayo JC; Manchester LC; Tan DX
    Ann N Y Acad Sci; 1999; 890():471-85. PubMed ID: 10668453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system.
    Reiter RJ; Acuña-Castroviejo D; Tan DX; Burkhardt S
    Ann N Y Acad Sci; 2001 Jun; 939():200-15. PubMed ID: 11462772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological actions of melatonin in oxygen radical pathophysiology.
    Reiter R; Tang L; Garcia JJ; Muñoz-Hoyos A
    Life Sci; 1997; 60(25):2255-71. PubMed ID: 9194681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oxidant/antioxidant network: role of melatonin.
    Reiter RJ; Tan DX; Cabrera J; D'Arpa D; Sainz RM; Mayo JC; Ramos S
    Biol Signals Recept; 1999; 8(1-2):56-63. PubMed ID: 10085463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective role of melatonin in oxidative stress vulnerable brain.
    Gupta YK; Gupta M; Kohli K
    Indian J Physiol Pharmacol; 2003 Oct; 47(4):373-86. PubMed ID: 15266948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actions of melatonin in the reduction of oxidative stress. A review.
    Reiter RJ; Tan DX; Osuna C; Gitto E
    J Biomed Sci; 2000; 7(6):444-58. PubMed ID: 11060493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin in relation to cellular antioxidative defense mechanisms.
    Reiter RJ; Carneiro RC; Oh CS
    Horm Metab Res; 1997 Aug; 29(8):363-72. PubMed ID: 9288572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of melatonin in antioxidative defense system: reactions and products.
    Tan DX; Manchester LC; Reiter RJ; Qi WB; Karbownik M; Calvo JR
    Biol Signals Recept; 2000; 9(3-4):137-59. PubMed ID: 10899700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive oxygen intermediates, molecular damage, and aging. Relation to melatonin.
    Reiter RJ; Guerrero JM; Garcia JJ; Acuña-Castroviejo D
    Ann N Y Acad Sci; 1998 Nov; 854():410-24. PubMed ID: 9928448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.
    Pandi-Perumal SR; BaHammam AS; Brown GM; Spence DW; Bharti VK; Kaur C; Hardeland R; Cardinali DP
    Neurotox Res; 2013 Apr; 23(3):267-300. PubMed ID: 22739839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the evidence supporting melatonin's role as an antioxidant.
    Reiter RJ; Melchiorri D; Sewerynek E; Poeggeler B; Barlow-Walden L; Chuang J; Ortiz GG; Acuña-Castroviejo D
    J Pineal Res; 1995 Jan; 18(1):1-11. PubMed ID: 7776173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidants and neuroprotection in the adult and developing central nervous system.
    Kaur C; Ling EA
    Curr Med Chem; 2008; 15(29):3068-80. PubMed ID: 19075654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin and nitric oxide.
    Aydogan S; Yerer MB; Goktas A
    J Endocrinol Invest; 2006 Mar; 29(3):281-7. PubMed ID: 16682846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence.
    Reiter RJ; Tan DX; Manchester LC; Qi W
    Cell Biochem Biophys; 2001; 34(2):237-56. PubMed ID: 11898866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of melatonin in neurodegenerative diseases.
    Srinivasan V; Pandi-Perumal SR; Maestroni GJ; Esquifino AI; Hardeland R; Cardinali DP
    Neurotox Res; 2005; 7(4):293-318. PubMed ID: 16179266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger.
    Tan DX; Reiter RJ; Manchester LC; Yan MT; El-Sawi M; Sainz RM; Mayo JC; Kohen R; Allegra M; Hardeland R
    Curr Top Med Chem; 2002 Feb; 2(2):181-97. PubMed ID: 11899100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.